Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis

Emerging Infectious Diseases

Volumn 15, Issue 7, 2009, Pages 1061-1067

  Burman, William J ^a,b   Bliven, Erin E ^c   Cowan, Lauren ^c   Bozeman, Lorna ^c   Nahid, Payam ^d   Diem, Lois ^c   Vernon, Andrew ^c  

^a Denver Public Health   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RIFAPENTINE; STREPTOMYCIN;

ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSAGE SCHEDULE COMPARISON; ETHNICITY; FEMALE; GENOTYPE; HUMAN; LUNG CAVITATION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PACIFIC ISLANDS; PATIENT COMPLIANCE; RELAPSE; RISK ASSESSMENT; RISK FACTOR; SPUTUM CULTURE; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS;

ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; HIV INFECTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RECURRENCE; RIFAMPIN; RISK FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 67650660065     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1507.081253     Document Type: Article

References (38)

1. Tuberculosis Trials Consortium. Once-weekly rifapentine and isoniazid versus twice-weekly rifampin and isoniazid in the continuation phase of therapy for drug-susceptible pulmonary tuberculosis: a prospective, randomized clinical trial among HIV-negative persons. Lancet. 2002;360:528-34. DOI: 10.1016/S0140-6736(02)09742-8
2. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, et al. The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. N Engl J Med. 1994;330:1179-84. DOI: 10.1056/ NEJM199404283301702
3. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet. 2001;358:1687-93. DOI: 10.1016/S0140-6736(01)06712-5
4. Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005;171:1430-5. DOI: 10.1164/rccm.200409-1200OC
5. Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, et al. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? Am J Respir Crit Care Med. 2004;170:1360-6. DOI: 10.1164/rccm.200408-1081OC
6. Zierski M, Bek E, Long MW, Snider DE Jr. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment. Am Rev Respir Dis. 1980;122:879-89.
7. Aber VR, Nunn AJ. Short-term chemotherapy of tuberculosis. Factors affecting relapse following short-course chemotherapy. Bull Int Union Tuberc. 1978;53:276-80.
8. Chang KC, Leung CC, Yew WW, Ho SC, Tam CM. A nested casecontrol study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med. 2004;170:1124-30. DOI: 10.1164/rccm.200407-905OC
9. Hong Kong Chest Service/Tuberculosis Research Centre Madras/ British Medical Research Council. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Am Rev Respir Dis. 1991;143:262-7.
10. Ramakrishnan CV, Bhatia AL, Fox W, Mitchison DA, Radhakrishna S, Selkon JB, et al. The virulence in the guinea-pig of tubercle bacilli isolated before treatment from South Indian patients with pulmonary tuberculosis. 3. Virulence related to pretreatment status of disease and to response to chemotherapy. Bull World Health Organ. 1961;25:323-38.
11. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, et al. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA. 2005;293:2726-31. DOI: 10.1001/jama.293.22.2726
12. Agerton TB, Valway SE, Blinkhorn RJ, Shilkret KL, Reves RR, Schulter WW, et al. Spread of Strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis. 1999;29:85-92. DOI: 10.1086/520187
13. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Garcia I, Cabrera P, et al. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med. 2001;164:1165-70.
14. Hanekom M, van der Spuy GD, Streicher E, Ndabambi SL, McEvoy CR, Kidd M, et al. A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause disease. J Clin Microbiol. 2007;45:1483-90. DOI: 10.1128/JCM.02191-06
15. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K, et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis. 2000;6:302-5.
16. Lan NT, Lien HT, Tung le B, Borgdorff MW, Kremer K, van Soolingen D. Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis. 2003;9:1633-5.
17. Sun YJ, Lee AS, Wong SY, Paton NI. Association of Mycobacterium tuberculosis Beijing genotype with tuberculosis relapse in Singapore. Epidemiol Infect. 2006;134:329-32. DOI: 10.1017/ S095026880500525X
18. Filliol I, Driscoll JR, van Soolingen D, Kreiswirth BN, Kremer K, Valetudie G, et al. Snapshot of moving and expanding clones of Mycobacterium tuberculosis and their global distribution assessed by spoligotyping in an international study. J Clin Microbiol. 2003;41:1963-70. DOI: 10.1128/JCM.41.5.1963-1970.2003
19. Hirsh AE, Tsolaki AG, DeRiemer K, Feldman MW, Small PM. Stable association between strains of Mycobacterium tuberculosis and their human host populations. Proc Natl Acad Sci U S A. 2004;101:4871-6. DOI: 10.1073/pnas.0305627101
20. Gagneux S, DeRiemer K, Van T, Kato-Maeda M, de Jong BC, Narayanan S, et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006;103:2869-73. DOI: 10.1073/pnas.0511240103
21. Gagneux S, Small PM. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis. 2007;7:328-37. DOI: 10.1016/S1473-3099 (07)70108-1
22. Vernon A, Burman W, Benator D, Khan A, Bozeman L. Relapse with rifamycin mono-resistant tuberculosis in HIV-infected patients treated with supervised once-weekly rifapentine and isoniazid. Lancet. 1999;353:1843-7. DOI: 10.1016/S0140-6736(98)11467-8
23. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993;31:406-9.
24. Molhuizen HO, Bunschoten AE, Schouls LM, van Embden JD. Rapid detection and simultaneous strain differentiation of Mycobacterium tuberculosis complex bacteria by spoligotyping. Methods Mol Biol. 1998;101:381-94.
25. Cowan LS, Diem L, Brake MC, Crawford JT. Transfer of a Mycobacterium tuberculosis genotyping method, spoligotyping, from a reverse line-blot hybridization, membrane-based assay to the Luminex multianalyte profiling system. J Clin Microbiol. 2004;42:474-7. DOI: 10.1128/JCM.42.1.474-477.2004
26. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis. 2002;8:843-9.
27. Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, Kreiswirth BN, et al. Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol. 2004;42:4040-9. DOI: 10.1128/JCM.42.9.4040-4049.2004
28. U.S. Census Bureau. Asian and Pacific Islander populations [cited 14 September 2008]. Available from http://www.census.gov/ population/www/socdemo/ race/api.html
29. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis. 2006;12:736-43.
30. Zhang M, Gong J, Yang Z, Samten B, Cave MD, Barnes PF. Enhanced capacity of a widespread strain of Mycobacterium tuberculosis to grow in human macrophages. J Infect Dis. 1999;179:1213-7. DOI: 10.1086/314738
31. Li Q, Whalen CC, Albert JM, Larkin R, Zukowski L, Cave MD, et al. Differences in rate and variability of intracellular growth of a panel of Mycobacterium tuberculosis clinical isolates within a human monocyte model. Infect Immun. 2002;70:6489-93. DOI: 10.1128/IAI.70.11.6489-6493.2002
32. Dormans J, Burger M, Aguilar D, Hernandez-Pando R, Kremer K, Roholl P, et al. Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB/c mouse model. Clin Exp Immunol. 2004;137:460-8. DOI: 10.1111/j.1365-2249.2004.02551.x
33. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, Ritacco V, et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol. 2003;133:30-7. DOI: 10.1046/j.1365-2249.2003.02171.x
34. Ebrahimi-Rad M, Bifani P, Martin C, Kremer K, Samper S, Rauzier J, et al. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis. 2003;9:838-45.
35. Kong Y, Cave MD, Zhang L, Foxman B, Marrs CF, Bates JH, et al. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J Clin Microbiol. 2007;45:409-14. DOI: 10.1128/JCM.01459-06
36. Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, Thuong NT, et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008;4:e1000034. DOI: 10.1371/journal.ppat.1000034
37. van Crevel R, Nelwan RH, de Lenne W, Veeraragu Y, van der Zanden AG, Amin Z, et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis. 2001;7:880-3.
38. Borgdorff MW, van Deutekom H, de Haas PE, Kremer K, van Soolingen D. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb). 2004;84:337-40. DOI: 10.1016/j. tube.2003.10.002